Insider Selling: Arteris, Inc. (NASDAQ:AIP) CEO Sells 50,000 Shares of Stock

Arteris, Inc. (NASDAQ:AIPGet Free Report) CEO K Charles Janac sold 50,000 shares of Arteris stock in a transaction on Monday, February 3rd. The stock was sold at an average price of $10.33, for a total value of $516,500.00. Following the transaction, the chief executive officer now directly owns 9,907,691 shares of the company’s stock, valued at approximately $102,346,448.03. This represents a 0.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.

K Charles Janac also recently made the following trade(s):

  • On Monday, January 6th, K Charles Janac sold 8,432 shares of Arteris stock. The shares were sold at an average price of $12.34, for a total transaction of $104,050.88.
  • On Thursday, January 2nd, K Charles Janac sold 6,256 shares of Arteris stock. The stock was sold at an average price of $11.41, for a total value of $71,380.96.
  • On Monday, December 30th, K Charles Janac sold 58,212 shares of Arteris stock. The shares were sold at an average price of $10.33, for a total transaction of $601,329.96.
  • On Thursday, December 26th, K Charles Janac sold 60,584 shares of Arteris stock. The stock was sold at an average price of $10.42, for a total value of $631,285.28.
  • On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The stock was sold at an average price of $10.01, for a total value of $141,941.80.
  • On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The shares were sold at an average price of $10.12, for a total value of $180,702.72.
  • On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The stock was sold at an average price of $8.58, for a total transaction of $10,656.36.

Arteris Stock Performance

NASDAQ AIP opened at $9.62 on Thursday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. Arteris, Inc. has a 1-year low of $5.76 and a 1-year high of $12.64. The firm has a market capitalization of $386.53 million, a P/E ratio of -10.02 and a beta of 1.18. The business’s 50-day simple moving average is $10.40 and its 200-day simple moving average is $8.60.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. US Bancorp DE purchased a new position in shares of Arteris in the 3rd quarter valued at $34,000. R Squared Ltd purchased a new position in Arteris in the fourth quarter valued at about $64,000. The Manufacturers Life Insurance Company acquired a new position in shares of Arteris during the second quarter worth about $86,000. Algert Global LLC purchased a new stake in shares of Arteris in the second quarter worth about $115,000. Finally, MetLife Investment Management LLC boosted its position in shares of Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock worth $131,000 after buying an additional 9,551 shares during the period. 64.36% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Separately, Rosenblatt Securities reaffirmed a “buy” rating and set a $15.00 price target on shares of Arteris in a research report on Wednesday, November 6th.

Check Out Our Latest Research Report on AIP

Arteris Company Profile

(Get Free Report)

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

Featured Stories

Insider Buying and Selling by Quarter for Arteris (NASDAQ:AIP)

Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.